跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XAZAL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
XAZAL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
XAZAL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Ucb Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 28, 2024
Approval ID
97dd3f3b12495833
Company
Ucb Pharma
Type
Standard
Approval Details
Approval Id
97dd3f3b12495833
Drug Cima Aemps Name
XAZAL 5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
228505
Holder Company Name
Ucb Pharma
Marketing Company Name
Difarmed S.L.U.
Holder Company Detail Path
/organization/ucb-pharma-sa
Authorization Date
2024-08-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg levocetirizina dihidrocloruro
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Ucb Pharma
Company Detail Path
/organization/ucb-pharma-sa
Company Information
Pharmaceutical Company Name
UCB S.A.
Name En
UCB S.A.
Country Name
Belgium
City Name
Brussels
Address
Brussels, Belgium
Website
https://www.ucb.com
Active Ingredients
LEVOCETIRIZINA DIHIDROCLORURO
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 28, 2024
Approval ID
97dd3f3b12495833
Type
Standard
Back to CIMA-AEMPS Approvals
